Medical Reviews

Thoughts on moderate-intensity statin combination therapy vs high-intensity statin monotherapy in clinical practice

As part of the REFLECTIONS - Dyslipidemia Global Newsletter #3, Prof. Michel Farnier (France) discusses the article "Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial".

Browse the full content of the Newsletter and access the written summary of the article by clicking on the link below: